Retrieve available abstracts of 188 articles: HTML format
Single Articles
October 2025
HIRANBURANA N, Sophonphan J, Kerr SJ, Ubolyam S, et al NAT2 polymorphisms and Antituberculosis-Induced Hepatotoxicity in Thai People
Living with HIV: Insights from a Pharmacogenetic-Pharmacokinetic Cohort Study.
J Infect Dis. 2025 Oct 1:jiaf511. doi: 10.1093. PubMedAbstract available
September 2025
COHEN C, Moore P Mechanistic insights into increased vulnerability to respiratory infections in
HIV-Exposed Uninfected Infants.
J Infect Dis. 2025 Sep 30:jiaf494. doi: 10.1093. PubMed
BOARDMAN SA, Hetherington C, Hughes T, Cook C, et al Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and
Therapies.
J Infect Dis. 2025 Sep 29:jiaf455. doi: 10.1093. PubMedAbstract available
KELLY C, Lester JS, Bradshaw D, Bibby DF, et al Real-world prevalence of non-integrase INSTI resistance-associated mutations and
virological outcomes in people who have recently acquired HIV-1 in the UK.
J Infect Dis. 2025 Sep 26:jiaf500. doi: 10.1093. PubMedAbstract available
BENLARBI M, Richard J, Clemente T, Bourassa C, et al Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily
Treatment-Experienced People With HIV.
J Infect Dis. 2025 Sep 24:jiaf461. doi: 10.1093. PubMedAbstract available
KOGILWAIMATH S, Utay NS "Fostemsavir: More Than Meets the Eye".
J Infect Dis. 2025 Sep 24:jiaf462. doi: 10.1093. PubMed
SMITH C, Curtis K, Bonham A, Boyer S, et al Maternal Inflammation Likely Drives Impaired Immune Responses to Respiratory
Syncytial Virus in HIV-Exposed Uninfected Infants.
J Infect Dis. 2025 Sep 24:jiaf493. doi: 10.1093. PubMedAbstract available
ALEMNJI G, Zeh C, Bhairavabhotla R, Wattleworth M, et al Implementation of All-inclusive Global Purchasing Agreements for Viral Load and
Infant Diagnosis in PEPFAR-Supported Countries.
J Infect Dis. 2025;232. PubMedAbstract available
GOMES DJ, Bancroft EA, Lawal I, Zender N, et al Advancing Infection Prevention and Control in the United States PEPFAR Programs.
J Infect Dis. 2025;232. PubMedAbstract available
MATTOCKS L, Celestin N, Francois K, Joseph P, et al PEPFAR Investments in Country Data Systems Support HIV Treatment Continuity: An
Example From Haiti.
J Infect Dis. 2025;232. PubMedAbstract available
BAPTISTE SL, Barr E, Reid MJA, Campbell DM, et al Unpacking the Role, Nature, and Need to Sustain Robust Community Responses in
Global Systems.
J Infect Dis. 2025;232. PubMedAbstract available
OKOYE M, Okoi C, Espy N, Mba N, et al Leveraging PEPFAR- and Global Fund-Supported Laboratory Network for Integrated
Disease Testing: Lessons From Integrated HIV, Tuberculosis, and COVID-19 Testing
in Nigeria.
J Infect Dis. 2025;232. PubMedAbstract available
ALEMNJI G, Sangthong A, Espy N, Bartee M, et al PEPFAR Laboratory Implementation Strategy as a Component of PEPFAR's 5-Year
Strategy.
J Infect Dis. 2025;232. PubMedAbstract available
CHIKWANDA P, Stevens T, Mwangi C, Phiri C, et al Leveraging Laboratory Information Management Systems to Support HIV and Other
Infectious Diseases Testing in PEPFAR-Supported Countries.
J Infect Dis. 2025;232. PubMedAbstract available
VERANI AR, Samo Gudo E, Chilengi R, Bratton S, et al PEPFAR Investments in National Public Health Institutes: HIV Control Through
Strong Systems.
J Infect Dis. 2025;232. PubMedAbstract available
BARTEE M, Yessick L, Maloney J, Tomlinson H, et al Diagonal Investments in Health Systems: PEPFAR's Approach to Sustaining the HIV
Response and Enhancing Global Health Security.
J Infect Dis. 2025;232. PubMedAbstract available
PAN C, Xu H, Huang M, He J, et al Mycobacterium tuberculosis PE_PGRS62 protein inhibits type I IFN responses to
promote HIV-2 replication by directly interacting with IRF3.
J Infect Dis. 2025 Sep 17:jiaf484. doi: 10.1093. PubMedAbstract available
LEONE P, Ferro A, Rolle CP, Lupo S, et al VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Anti-drug
Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study
Results.
J Infect Dis. 2025 Sep 2:jiaf450. doi: 10.1093. PubMedAbstract available
August 2025
CHURIWAL M, Kintu TM, Byamukama O, Bassett IV, et al HIV and syphilis coinfection in pregnancy and adverse birth outcomes in Uganda.
J Infect Dis. 2025 Aug 30:jiaf453. doi: 10.1093. PubMedAbstract available
LABARILE M, Schoepf IC, Pasin C, Oumelloul MA, et al Untargeted Metabolite Profile Associations with Body Mass Index, Waist-Hip Ratio,
and Antiretroviral Therapy in >1300 People with HIV: the Swiss HIV Cohort Study.
J Infect Dis. 2025 Aug 27:jiaf438. doi: 10.1093. PubMedAbstract available
RUTAKINGIRWA MK, Ssebambulidde K, Okurut S, Kwizera R, et al Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of
2-week and 1-year survival among Persons with HIV-Associated Cryptococcal
Meningitis.
J Infect Dis. 2025 Aug 21:jiaf449. doi: 10.1093. PubMedAbstract available
KELLER MJ, Wang T, Murphy K, Serrano MG, et al Cervicovaginal Secretions in Young Women with Bacterial Vaginosis Enhance HIV
Infection.
J Infect Dis. 2025 Aug 21:jiaf444. doi: 10.1093. PubMedAbstract available
GAO Q, Lan X, Yang F, Yu H, et al Prognostic Divergence in HIV/HBV vs. HBV- Associated HCC after Resection:
Intrahepatic Pre-S Deletions Mutants and T-cell Depletion under Viral
Suppression.
J Infect Dis. 2025 Aug 14:jiaf433. doi: 10.1093. PubMedAbstract available
NDHLOVU LC, Giron LB, Galinskas J, Premeaux TA, et al Virological and Immunological Outcomes of Combined Therapeutic Interventions and
Dendritic Cell Therapy in People Living with HIV.
J Infect Dis. 2025 Aug 14:jiaf430. doi: 10.1093. PubMedAbstract available
JUDSON SD, Orkin CM, Gebo K Mpox: What Have We Learned and How Do We Better Prepare for the Future?
J Infect Dis. 2025;232:270-273. PubMedAbstract available
PATEL SM, Farirai J, Patel MZ, Boiditswe S, et al Alterations of the upper respiratory microbiome among children living with HIV
infection in Botswana.
J Infect Dis. 2025 Aug 12:jiaf429. doi: 10.1093. PubMedAbstract available
GIANELLA S, Taylor J, Shelton B, Martinez N, et al Every Body Has Value: Ending Discriminatory Restrictions on Anatomical Donations.
J Infect Dis. 2025 Aug 6:jiaf413. doi: 10.1093. PubMedAbstract available
SAMANDARI T, Achola M, Hutter JN, Mboya G, et al Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody
Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults.
J Infect Dis. 2025 Aug 2:jiaf398. doi: 10.1093. PubMedAbstract available
July 2025
OBER V, Volk F, Sbierski-Kind J, Gruner E, et al Systemic and SARS-CoV-2 specific Immune Disturbances in Individuals With
Post-COVID Syndrome.
J Infect Dis. 2025;232:50-59. PubMedAbstract available
KELLEY CF, Weddle A, Agwu A, Bolduc PJ, et al Persistence is Resistance: The fight to End the HIV Epidemic Hangs in the
Balance.
J Infect Dis. 2025 Jul 28:jiaf389. doi: 10.1093. PubMed
GORDON B, Nyiro JU, Nair H, Sheikh Z, et al External validation of paediatric pneumonia and bronchiolitis risk scores to
predict mortality in children hospitalised in Kenya: a retrospective cohort
study.
J Infect Dis. 2025 Jul 22:jiaf377. doi: 10.1093. PubMedAbstract available
LI M, Truong K, Sharma S, Sun B, et al Elimination of HIV Reservoirs Harboring Intact Proviruses.
J Infect Dis. 2025 Jul 16:jiaf373. doi: 10.1093. PubMedAbstract available
MOHAN H, Nguyen J, Yee A, Laurette EY, et al Fetal Defects in Mice Treated with Integrase Strand Transfer Inhibitors:
Comparison of Dolutegravir, Raltegravir, Bictegravir and Cabotegravir.
J Infect Dis. 2025 Jul 15:jiaf362. doi: 10.1093. PubMedAbstract available
MALEYEFF L, Moodie EEM, Golchi S SMART Designs: Bridging the Gap Between Clinical Trials and Practice in
Infectious Diseases.
J Infect Dis. 2025;231:1353-1356. PubMedAbstract available
FARRELL-SHERMAN A, de la Force N, Prator CA, Valieris R, et al Antiviral Monocytes Increase Prior to Detectable HIV-1 Rebound Viremia.
J Infect Dis. 2025 Jul 9:jiaf367. doi: 10.1093. PubMedAbstract available
YOON H, Nakouzi AS, Wake RM, Day J, et al Comparative analysis of glucuronoxylomannogalactan (GXMGal) and
glucuronoxylomannan (GXM) antibody responses and their associations with
cryptococcal disease status in people living with HIV.
J Infect Dis. 2025 Jul 8:jiaf366. doi: 10.1093. PubMedAbstract available
PEARSON RA, Krish KN, Whatney WE, Jaoko W, et al Single-cell transcriptomics reveals depletion and dysregulation of Mycobacterium
tuberculosis-specific Th1 and Th17 cells early after acquisition of HIV.
J Infect Dis. 2025 Jul 3:jiaf354. doi: 10.1093. PubMedAbstract available
June 2025
BAUERMEISTER JA, Arrington-Sanders R, Coleman-Lewis J, Bertagnolli LN, et al Safety, Pharmacokinetics, and Acceptability of a Tenofovir Rectal Microbicide
Douche Among Young Men Who Have Sex with Men: The DREAM ATN Study (ATN 163).
J Infect Dis. 2025 Jun 28:jiaf349. doi: 10.1093. PubMedAbstract available
KRAEF C, Omland LH, Porskrog A, Larsen CS, et al Risk of cancer after tuberculosis disease among people with HIV in Denmark: a
nationwide population-based cohort study.
J Infect Dis. 2025 Jun 26:jiaf341. doi: 10.1093. PubMedAbstract available
CHEN J, Zhao L, Zhou X, Mo Y, et al Safety and Diagnostic Performance of Recombinant Fusion Protein ESAT6-CPF10 Skin
Test in A Large Population: A Phase IV Clinical Trial.
J Infect Dis. 2025 Jun 25:jiaf332. doi: 10.1093. PubMedAbstract available
PERAZZOLO S, Flexner CW, Stephen ZR, Acosta EP, et al Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir
Pharmacokinetic Enhancement.
J Infect Dis. 2025 Jun 24:jiaf319. doi: 10.1093. PubMedAbstract available
RYCKMAN TS, Hopkins L, Tang L, Biche P, et al Molecular epidemiology of Mycobacterium tuberculosis across three distinct
geographic sites in South Africa.
J Infect Dis. 2025 Jun 17:jiaf326. doi: 10.1093. PubMedAbstract available
NTSHIQA T, Nagudi J, Hamada Y, Copas A, et al Risk factors associated with TB infection among household contacts of
microbiologically confirmed pulmonary TB patients in three high TB burden
countries.
J Infect Dis. 2025 Jun 17:jiaf320. doi: 10.1093. PubMedAbstract available
NOVITSKY V, Steingrimsson J, Guang A, Gillani FS, et al Newly Diagnosed Individuals in Molecular HIV-1 Clusters in Rhode Island over
Three Decades.
J Infect Dis. 2025 Jun 12:jiaf313. doi: 10.1093. PubMedAbstract available
HURST JR, Tan DHS, Li A, Khera SS, et al Monkeypox virus transcriptional profiles and host responses in skin lesion swabs
among individuals with HIV.
J Infect Dis. 2025 Jun 11:jiaf316. doi: 10.1093. PubMedAbstract available
YAN A, Kundu S, Samuels DC, Bailin S, et al Mitochondrial DNA Haplogroups, Biomarkers of Inflammation and Immune Activation,
and Risk of Diabetes in Veterans with and without HIV.
J Infect Dis. 2025 Jun 9:jiaf304. doi: 10.1093. PubMedAbstract available
VAN RENSBURG R, Kellermann T, Pillay-Fuentes Lorente V, du Plessis C, et al Reduced metformin concentrations in obese women with HIV treated with
dolutegravir.
J Infect Dis. 2025 Jun 5:jiaf305. doi: 10.1093. PubMedAbstract available
May 2025
ZHENG R, Fuchs EJ, Nimmagadda S, Rohan LC, et al Anal Sex and Tenofovir Douche Sequence Impacts Colorectal Distribution of HIV
Surrogate and Douche (DREAM-02).
J Infect Dis. 2025 May 31:jiaf286. doi: 10.1093. PubMedAbstract available
MORO RN, Johnson JL, Martinson N, Muzanyi G, et al Differences in Neutrophil Counts Between African and non-African Countries in two
International Clinical Trials.
J Infect Dis. 2025 May 31:jiaf291. doi: 10.1093. PubMedAbstract available
ROZEK GM, Yang P, Eby Y, Benner SE, et al HIV-Superinfection in Kidney Transplant Recipients with HIV who Received Organs
from Donors with HIV.
J Infect Dis. 2025 May 29:jiaf284. doi: 10.1093. PubMedAbstract available
WEGERMANN K, Lucas JE, Dubois L, Mangus R, et al Plasma lipid metabolites differentiate metabolic from viral chronic liver
disease.
J Infect Dis. 2025 May 23:jiaf270. doi: 10.1093. PubMedAbstract available
WILLENBERG L, Freshwater W, Averitt D, Scruggs LH, et al The Cost of Silence: A Call to Protect the Future of HIV Research and Care.
J Infect Dis. 2025 May 22:jiaf267. doi: 10.1093. PubMed
YU F, Ma P, Duan J Reevaluating the clinical relevance of bacterial vaginosis-associated immune
responses in HIV infection.
J Infect Dis. 2025 May 14:jiaf227. doi: 10.1093. PubMed
ROBINSON-PAPP J, Mehta M, Mueller BR, Neupane N, et al Gastrointestinal Dysmotility, Autonomic Function and Small Intestinal Bacterial
Overgrowth among People with Well-Controlled HIV.
J Infect Dis. 2025 May 13:jiaf238. doi: 10.1093. PubMedAbstract available
COLLINS JM, Bobosha K, Narayanan N, Gandhi NR, et al A plasma metabolic signature to diagnose pulmonary tuberculosis and monitor
treatment response.
J Infect Dis. 2025 May 8:jiaf240. doi: 10.1093. PubMedAbstract available
CORPUZ JCG Tackling HIV Drug Resistance in the Philippines: A Call to Action.
J Infect Dis. 2025 May 7:jiaf236. doi: 10.1093. PubMed
HILLIER SL, Bekker LG, Riddler SA, Hendrix CW, et al Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: a
Phase 2a Study in Participants at Low Risk for Acquiring HIV-1.
J Infect Dis. 2025 May 6:jiaf222. doi: 10.1093. PubMedAbstract available
ROSEN EP, White N, Sykes C, Adamson L, et al Heterogeneous antiretroviral drug exposure in male and female genital tract
tissues.
J Infect Dis. 2025 May 5:jiaf225. doi: 10.1093. PubMedAbstract available
April 2025
ATMAR RL, Lyke KE, Posavad CM, Deming ME, et al Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger
RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
J Infect Dis. 2025 Apr 29:jiaf176. doi: 10.1093. PubMedAbstract available
ABDELGAWAD N, Wasserman S, Gausi K, Davis A, et al Population Pharmacokinetics of Rifampicin in Plasma and Cerebrospinal Fluid in
Adults With Tuberculosis Meningitis.
J Infect Dis. 2025 Apr 29:jiaf178. doi: 10.1093. PubMedAbstract available
LIU Z, Julius P, Yalcin D, Kang G, et al Cellular Tropism and Viral Genetics in Appendix Tissue Reservoirs of Subtype C
HIV-1 Infected Aviremic Persons.
J Infect Dis. 2025 Apr 25:jiaf201. doi: 10.1093. PubMedAbstract available
PATEL RC, Ndlovu N, Maheria P, Kgoa R, et al Pharmacokinetic and clinical associations between doravirine-containing ART and
injectable and implantable hormonal contraceptive methods among women living with
HIV in South Africa.
J Infect Dis. 2025 Apr 22:jiaf196. doi: 10.1093. PubMedAbstract available
BEGRE L, Akotia MK, Wembulua BS, Pandi M, et al Circulating HBV RNA and conventional HBV markers in treatment-naive persons with
HBV in Senegal.
J Infect Dis. 2025 Apr 19:jiaf190. doi: 10.1093. PubMedAbstract available
RONN MM, Chesson HW, Grad YH, Reitsma M, et al The influence of epidemiological context on the success of partner notification
programs: analysis of gonorrhea transmission dynamics.
J Infect Dis. 2025 Apr 18:jiaf206. doi: 10.1093. PubMedAbstract available
WANG Y, Brichacek B, Dubrovsky L, Pushkarsky T, et al Increased atherosclerosis in HIV-infected humanized mice is caused by a single
viral protein, Nef.
J Infect Dis. 2025 Apr 16:jiaf192. doi: 10.1093. PubMedAbstract available
LOURENS R, Singh G, Arendse T, Thwaites G, et al Tuberculous meningitis across the lifespan.
J Infect Dis. 2025 Apr 8:jiaf181. doi: 10.1093. PubMedAbstract available
ERON JJ, Cook PP, Mehrotra ML, Huang H, et al Lenacapavir Plus Two Broadly Neutralizing Antibodies, Teropavimab and
Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or
Zinlirvimab.
J Infect Dis. 2025 Apr 3:jiaf159. doi: 10.1093. PubMedAbstract available
MUNOZ-MUELA E, Mejias-Trueba M, Serna-Gallego A, Saborido-Alconchel A, et al Mitochondrial disorders after 12 months of HIV-1 preexposure prophylaxis based on
tenofovir disoproxil fumarate plus emtricitabine in healthy adults.
J Infect Dis. 2025 Apr 1:jiaf156. doi: 10.1093. PubMedAbstract available
March 2025
KLASTRUP V, Gunst JD, Rasmussen TA, Tolstrup M, et al Factors influencing virologic control during analytical treatment interruptions
in HIV cure trials - a pooled analysis of individual level data.
J Infect Dis. 2025 Mar 26:jiaf163. doi: 10.1093. PubMedAbstract available
TOLEDO JP Empowering Futures: Restoring T Cell Responses in Children Living with HIV.
J Infect Dis. 2025 Mar 26:jiaf160. doi: 10.1093. PubMedAbstract available
ROSTAD CA, Campbell JD, Paulsen GC, Schnyder Ghamloush S, et al Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6
Months to 11 Years of Age.
J Infect Dis. 2025 Mar 22:jiaf144. doi: 10.1093. PubMedAbstract available
MADHI SA, Simoes EAF, Acevedo A, Novoa Pizarro JM, et al A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus
Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.
J Infect Dis. 2025;231:e478-e487. PubMedAbstract available
SHAIKH MW, Singh S, Giron LB, Zhang L, et al Compromised Intestinal Barrier Resilience to Disruption in People with HIV.
J Infect Dis. 2025 Mar 6:jiaf119. doi: 10.1093. PubMedAbstract available
MASIA M, Fernandez-Gonzalez M, Ledesma C, Losada-Echeberria M, et al Impact of switching to long-acting injectable cabotegravir plus rilpivirine on
rectal HIV-1 RNA shedding and implications for transmission risk.
J Infect Dis. 2025 Mar 5:jiaf117. doi: 10.1093. PubMedAbstract available
CHESSON HW, Markowitz LE Strong Herd Effects of Human Papillomavirus Vaccination.
J Infect Dis. 2025 Mar 5:jiaf121. doi: 10.1093. PubMed
VAN GERWEN OT, Aaron KJ, Kay ES, Siwakoti K, et al The Impact of Testosterone Therapy on the Vaginal Microbiota of Transgender Men
and Non-Binary People: A Prospective Study.
J Infect Dis. 2025 Mar 3:jiaf114. doi: 10.1093. PubMedAbstract available
February 2025
DE GREEF J, Yombi JC, Vincent A, Vandercam B, et al Dolutegravir and Risk of Neuropsychiatric Adverse Events: a Pharmacogenetic
Study.
J Infect Dis. 2025 Feb 26:jiaf098. doi: 10.1093. PubMedAbstract available
CHOW FC, Kafeero P, Muhumuza P, Nakimbugwe M, et al Safety and Tolerability of a Short Course of Linezolid for the Treatment of
Predominantly Moderate to Severe Tuberculous Meningitis in Adults with HIV.
J Infect Dis. 2025 Feb 17:jiaf089. doi: 10.1093. PubMedAbstract available
YOUNAS M, Gimenez S, Lin YL, Mettling C, et al GABA-induced monocytic reactive oxygen species impair CD4 restoration in treated
HIV-1 adults.
J Infect Dis. 2025 Feb 4:jiaf058. doi: 10.1093. PubMedAbstract available
January 2025
SABO MC, Mustafa S, Saha A, Oyaro B, et al Bacterial vaginosis is associated with transcriptomic changes but not higher
concentrations of cervical leukocytes in a study of women at high risk for HIV
acquisition.
J Infect Dis. 2025 Jan 28:jiaf049. doi: 10.1093. PubMedAbstract available
MARGOT NA, Jogiraju V, Pennetzdorfer N, Naik V, et al Resistance Analyses in Heavily Treatment-Experienced People with HIV Treated with
the Novel HIV Capsid Inhibitor Lenacapavir After 2 years.
J Infect Dis. 2025 Jan 28:jiaf050. doi: 10.1093. PubMedAbstract available
MACCANN R, Li J, Leon AAG, Negi R, et al Associations between the gut microbiome, inflammation and cardiovascular profiles
in people with HIV.
J Infect Dis. 2025 Jan 24:jiaf043. doi: 10.1093. PubMedAbstract available
PETERS BA, Xue X, Hanna DB, Wang Y, et al Healthy Aging and the Gut Microbiome in People With and Without HIV.
J Infect Dis. 2025 Jan 22:jiae644. doi: 10.1093. PubMedAbstract available
ELLIS RJ, Vaida F, Hu K, Dube M, et al Effects of Tesamorelin on Neurocognitive Impairment in Abdominally Obese Persons
with HIV.
J Infect Dis. 2025 Jan 15:jiaf012. doi: 10.1093. PubMedAbstract available
December 2024
DABEER S, Tripathi AK, Weiss D, Vikulina T, et al Combined Sequential Antiretroviral Therapy-Induced Immune Reconstitution Bone
Loss and Estrogen Deficiency Bone Loss are Cumulative in Mice Models.
J Infect Dis. 2024 Dec 27:jiae643. doi: 10.1093. PubMedAbstract available
MUKERJI SS, Bachanova P, Park H, Rosen LV, et al Plasma Neurofilament Light Chain and Glial Fibrillary Acidic Protein as
Biomarkers of Cognitive Decline in People Living with HIV.
J Infect Dis. 2024 Dec 26:jiae623. doi: 10.1093. PubMedAbstract available
OMOLE TE, Nguyen HM, Marcinow A, Oo MM, et al Pre-HIV alpha4beta7hi CD4+ T cells and HIV risk among heterosexual individuals in
Africa.
J Infect Dis. 2024 Dec 25:jiae638. doi: 10.1093. PubMedAbstract available
DIAS GONCALVES LIMA F, Rozemeijer K, van der Zee RP, Dick S, et al DNA methylation analysis on anal swabs for anal cancer screening in people living
with HIV.
J Infect Dis. 2024 Dec 24:jiae627. doi: 10.1093. PubMedAbstract available
DAY CL, Njuguna IN, Cranmer LM, Whatney WE, et al Patterns and cofactors of polyfunctional mycobacteria-specific T cell response
restoration following 6-month antiretroviral treatment in children living with
HIV.
J Infect Dis. 2024 Dec 18:jiae630. doi: 10.1093. PubMedAbstract available
MEHTA SR, Wells AB, Cohen C, Campbell A, et al Phylodynamics for HIV Prevention: A Miami-Dade Case Study.
J Infect Dis. 2024 Dec 17:jiae605. doi: 10.1093. PubMedAbstract available
WILSON GJ, Church LWP, Kelley CF, Robinson ST, et al HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of
CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines.
J Infect Dis. 2024 Dec 13:jiae558. doi: 10.1093. PubMedAbstract available
GIANELLA S, Yu T, Wang R, Ignacio C, et al Viral and Immune Risk Factors of HIV Rebound after Interruption of Antiretroviral
Therapy.
J Infect Dis. 2024 Dec 11:jiae585. doi: 10.1093. PubMedAbstract available
VANBELLINGHEN MC, Boyd A, Kootstra NA, Schim van der Loeff MF, et al A biomarker profile reflective of preserved thymic function is associated with
reduced comorbidities in ageing people with HIV: an AGEhIV Cohort analysis.
J Infect Dis. 2024 Dec 10:jiae603. doi: 10.1093. PubMedAbstract available
BAILIN SS, Ma S, Perry AS, Terry JG, et al The Primacy of Adipose Tissue Gene Expression and Plasma Lipidome in
Cardiometabolic Disease in Persons With HIV.
J Infect Dis. 2024 Dec 9:jiae532. doi: 10.1093. PubMedAbstract available
WANG J, Genberg BL, Feder K, Kirk GD, et al Impact of pandemic-induced service disruptions and behavioral changes on HCV and
HIV transmission amongst people who inject drugs: a modeling study.
J Infect Dis. 2024 Dec 6:jiae599. doi: 10.1093. PubMedAbstract available
SACHITHANANDHAM J, Leep-Lazar J, Quinn J, Bowden K, et al Direct acting antivirals eradicate HCV from the liver quickly in people with HIV
but do not fully reverse immune activation.
J Infect Dis. 2024 Dec 4:jiae598. doi: 10.1093. PubMedAbstract available
November 2024
STRICKLER HD, Usyk M, Eltoum IE, Bachman N, et al Case-Control Study of Cervicovaginal Beta-/Gamma-HPV Infection in Women with HIV
and Its Relation with Incident Cervical Precancer.
J Infect Dis. 2024 Nov 27:jiae588. doi: 10.1093. PubMedAbstract available
VELLAS C, Martres D, Requena M, Nayrac M, et al Compartmentalized HIV-1 reservoir in intestinal monocytes/macrophages on
antiretroviral therapy.
J Infect Dis. 2024 Nov 19:jiae557. doi: 10.1093. PubMedAbstract available
COHEN C, du Plessis M, Martinson N, Moyes J, et al A potential platform for future vaccine trials identifies high incidence of
symptomatic and asymptomatic influenza infection among children aged 6-23 months
in South Africa.
J Infect Dis. 2024 Nov 14:jiae550. doi: 10.1093. PubMedAbstract available
ULFHAMMER G, Yilmaz A, Mellgren A, Tyrberg E, et al Asymptomatic Cerebrospinal Fluid HIV-1 Escape: Incidence and Consequences.
J Infect Dis. 2024 Nov 12:jiae555. doi: 10.1093. PubMedAbstract available
MAGOMBEDZE G, Vendrame E, SenGupta D, Geleziunas R, et al Early Viral Dynamics Predict HIV Post-Treatment Control After Analytic Treatment
Interruption.
J Infect Dis. 2024 Nov 8:jiae551. doi: 10.1093. PubMedAbstract available
October 2024
TOBIN NH, Brooker SL, Li F, Coombs RW, et al Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial
Communities in Women with HIV.
J Infect Dis. 2024 Oct 31:jiae524. doi: 10.1093. PubMedAbstract available
BAILON L, Puertas MC, Garcia-Guerrero MC, Moraes-Cardoso I, et al Impact of Dolutegravir plus Lamivudine as First-Line Antiretroviral Treatment on
HIV-1 Reservoir and Inflammatory Markers in Peripheral Blood.
J Infect Dis. 2024 Oct 28:jiae530. doi: 10.1093. PubMedAbstract available
PAHUS MH, Zheng Y, Olefsky M, Gunst JD, et al Evaluation and real-world experience of a neutralization susceptibility screening
assay for broadly neutralizing anti-HIV-1 antibodies.
J Infect Dis. 2024 Oct 23:jiae486. doi: 10.1093. PubMedAbstract available
ARMISTEAD B, Peters MQ, Houck J, Carlson M, et al Exposure to HIV is associated with altered composition of maternal microchimeric
T cells in infants.
J Infect Dis. 2024 Oct 22:jiae521. doi: 10.1093. PubMedAbstract available
TRUSCELLO E, Wang S, Young J, Sebastiani G, et al Changes in hepatic steatosis before and after direct acting antiviral treatment
in people living with HIV and Hepatitis C coinfection.
J Infect Dis. 2024 Oct 17:jiae487. doi: 10.1093. PubMedAbstract available
RAJAGOPALAN S, Rourke AK, Asare E, Kohlerschmidt DJ, et al Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline,
Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium
tuberculosis Clinical Isolates.
J Infect Dis. 2024 Oct 16:jiae438. doi: 10.1093. PubMedAbstract available
CHEN J, Chang Y, Wu Y, Tang H, et al Trends, Age-Period-Cohort Effects, and Projections in the Incidence and Mortality
of HIV/AIDS among the Elderly in China.
J Infect Dis. 2024 Oct 15:jiae485. doi: 10.1093. PubMedAbstract available
September 2024
DIRAJLAL-FARGO S, Nikahd M, Ailstock K, Manubolu M, et al Changes in the lipidome are associated with immune activation and subclinical
vascular disease in youth with HIV in Uganda.
J Infect Dis. 2024 Sep 27:jiae461. doi: 10.1093. PubMedAbstract available
NGUYEN HC, Lal KG, Balinsky CA, Hontz RD, et al Informing the Need for a SARS-CoV-2 Booster Based on the Immune Responses Among
Young Healthy Adults to Variants Circulating in Late 2023.
J Infect Dis. 2024;230:645-656. PubMedAbstract available
LIN LY, Gantner P, Li S, Su B, et al Unpredicted protective function of Fc-mediated inhibitory antibodies for HIV and
SARS-CoV-2 vaccines.
J Infect Dis. 2024 Sep 20:jiae464. doi: 10.1093. PubMedAbstract available
RUBIN LH, Shirk EN, Pohlenz L, Romero H, et al Intact HIV reservoir in monocytes is associated with cognitive function in
virally suppressed women with HIV.
J Infect Dis. 2024 Sep 18:jiae460. doi: 10.1093. PubMedAbstract available
NGUYEN HT, Chikata T, Zhang Y, Tran GV, et al Role of HLA-B*58:01-restricted CD8+ T cells in HIV-1 subtype AE infection.
J Infect Dis. 2024 Sep 9:jiae448. doi: 10.1093. PubMedAbstract available
SRINIVASAN S, Richardson BA, Wallis JM, Fiedler TL, et al Vaginal Bacteria and Proinflammatory Host Immune Mediators as Biomarkers of Human
Immunodeficiency Virus Acquisition Risk Among African Women.
J Infect Dis. 2024 Sep 9:jiae406. doi: 10.1093. PubMedAbstract available
DE SCHEERDER MA, Degroote S, Delporte M, Kiselinova M, et al In depth analysis of the HIV reservoir confirms effectiveness and safety of
DTG/3TC in a phase 4 randomized controlled switch trial (RUMBA).
J Infect Dis. 2024 Sep 3:jiae405. doi: 10.1093. PubMedAbstract available
JANES H, Fisher LH, Kee JJ, Parameswaran L, et al Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3
Trials.
J Infect Dis. 2024 Sep 3:jiae400. doi: 10.1093. PubMedAbstract available
WALKER NF, Schutz C, Ward A, Barr D, et al Elevated Plasma Matrix Metalloproteinases Are Associated With Mycobacterium
tuberculosis Bloodstream Infection and Mortality in Human Immunodeficiency
Virus-Associated Tuberculosis.
J Infect Dis. 2024 Sep 2:jiae296. doi: 10.1093. PubMedAbstract available
August 2024
SERRANO-RISQUEZ C, Omar M, Rallon N, Benito JM, et al Impact of HLA allele-KIR partners on sexually transmitted HIV-1 infection.
J Infect Dis. 2024 Aug 29:jiae436. doi: 10.1093. PubMedAbstract available
AN M, Zheng C, Chen L, Li H, et al Sustained Spread of HIV-1 CRF55_01B in Its Place of Initial Origin: Dynamics and
Hotspots.
J Infect Dis. 2024 Aug 29:jiae428. doi: 10.1093. PubMedAbstract available
CHAIMONGKOL N, Kim DY, Matsushima Y, Durkee-Shock J, et al A Decade of Chronic Norovirus Infection Surveillance at the NIH Clinical Research
Center: Clinical Characteristics, Molecular Epidemiology, and Replication.
J Infect Dis. 2024 Aug 29:jiae440. doi: 10.1093. PubMedAbstract available
SERRANO-VILLAR S, Gala A, Bacchetti P, Hoh R, et al Galectin-9 Levels as a Potential Predictor of Intact HIV Reservoir Decay.
J Infect Dis. 2024 Aug 28:jiae426. doi: 10.1093. PubMedAbstract available
OKAFOR EC, Mukaremera L, Hullsiek KH, Engen N, et al CSF Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of
Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal Meningitis.
J Infect Dis. 2024 Aug 28:jiae421. doi: 10.1093. PubMedAbstract available
PATEL D, Mulatu MS, Wang G, May AC, et al CDC-Funded HIV Testing Services Outcomes in Ending the HIV Epidemic in the U.S.
(EHE) and Non-EHE Jurisdictions, 2021.
J Infect Dis. 2024 Aug 28:jiae430. doi: 10.1093. PubMedAbstract available
YE J, Dong Y, Lan Y, Chen J, et al Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to
2023.
J Infect Dis. 2024 Aug 27:jiae303. doi: 10.1093. PubMedAbstract available
YE J, Lan Y, Wang J, Feng Y, et al Improvement in the 95-95-95 Targets Is Accompanied by a Reduction in Both the
Human Immunodeficiency Virus Transmission Rate and Incidence in China.
J Infect Dis. 2024 Aug 26:jiae302. doi: 10.1093. PubMedAbstract available
DOYLE RM, Kannambath S, Pittman A, Goliath R, et al Ex vivo host transcriptomics during Cryptococcus neoformans, Cryptococcus gattii,
and Candida albicans infection of PBMCs from South African volunteers.
J Infect Dis. 2024 Aug 19:jiae410. doi: 10.1093. PubMedAbstract available
D'ENTREMONT-HARRIS M, Ramsey TD, Pelletier E, Goodall B, et al Reply to Antinori and Bausch-Jurken.
J Infect Dis. 2024;230:524-526. PubMed
DESISTO CL, Winer RL, Querec TD, Dada D, et al Vaccine effectiveness against anal HPV among men who have sex with men aged 18-45
years attending sexual health clinics in three United States cities, 2018-2023.
J Infect Dis. 2024 Aug 8:jiae394. doi: 10.1093. PubMedAbstract available
July 2024
ABARA WE, Kirkcaldy RD, Bernstein KT, Galloway E, et al Effectiveness of MenB-4C vaccine against gonorrhea: a systematic review and
meta-analysis.
J Infect Dis. 2024 Jul 31:jiae383. doi: 10.1093. PubMedAbstract available
TANTALO LC, Luetkemeyer A, Lieberman NAP, Nunley BE, et al Long-term in vitro exposure of Treponema pallidum to sub-bactericidal doxycycline
did not induce resistance: Implications for doxy-PEP and syphilis.
J Infect Dis. 2024 Jul 27:jiae381. doi: 10.1093. PubMedAbstract available
ELLIOT ER, Polli JW, Patel P, Garside L, et al Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b
Long-Acting Cabotegravir Plus Rilpivirine Trials.
J Infect Dis. 2024;230:e34-e42. PubMedAbstract available
ALLEN LI, Fraser H, Stone J, McAuley A, et al Testing and Treatment Interventions in Community Settings Key to Controlling a
Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in
Glasgow: A Modeling Study.
J Infect Dis. 2024;230:e48-e59. PubMedAbstract available
JOHNSON JA, Li JF, Politch JA, Lipscomb JT, et al HIV Immunocapture Reveals Particles Expressed in Semen Under Integrase Strand
Transfer Inhibitor-Based Therapy Are Largely Myeloid Cell-Derived and Disparate.
J Infect Dis. 2024;230:78-85. PubMedAbstract available
BURDORF RM, Zhou S, Amon C, Long N, et al Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance
Mutations on Antiretroviral Therapy Outcomes.
J Infect Dis. 2024;230:86-94. PubMedAbstract available
WANG X, Zhang Y, Xiao J, Song C, et al Effect of Vaginal Microecological Disorders on the Increased Risk of Abnormal
Cervical Cytology Among Women With Human Immunodeficiency Virus in China.
J Infect Dis. 2024;230:61-66. PubMedAbstract available
VAN DE WEG CAM, Thomazella MV, Marmorato MP, Correia CA, et al Levels of Angiopoietin 2 Are Predictive for Mortality in Patients Infected With
Yellow Fever Virus.
J Infect Dis. 2024;230:e60-e64. PubMedAbstract available
COMBES JD, Didelot JM, Radenne S, Zaegel-Faucher O, et al Cumulative Detection of Anal High-Grade Squamous Intraepithelial Lesions Over
2-Year Follow-up in Men Who Have Sex With Men Living With Human Immunodeficiency
Virus in France.
J Infect Dis. 2024;230:55-60. PubMedAbstract available
VAN TEIJLINGEN NH, van Smoorenburg MY, Sarrami-Forooshani R, Zijlstra-Willems EM, et al Prevotella timonensis Bacteria Associated With Vaginal Dysbiosis Enhance Human
Immunodeficiency Virus Type 1 Susceptibility Of Vaginal CD4+ T Cells.
J Infect Dis. 2024;230:e43-e47. PubMedAbstract available
WILCOX CS, Herbert C, Wang C, Ma Y, et al Signals From Inflamed Perivascular Adipose Tissue Contribute to Small-Vessel
Dysfunction in Women With Human Immunodeficiency Virus.
J Infect Dis. 2024;230:67-77. PubMedAbstract available
LANTZ A, Kiweewa Matovu F, Johnson R, Isingel E, et al Female genital tract host factors and tenofovir and lamivudine active
metabolites.
J Infect Dis. 2024 Jul 24:jiae372. doi: 10.1093. PubMedAbstract available
GILS T, Hella J, Jacobs BKM, Sossen B, et al A prospective evaluation of the diagnostic accuracy of the point-of-care VISITECT
CD4 Advanced Disease test in seven countries.
J Infect Dis. 2024 Jul 24:jiae374. doi: 10.1093. PubMedAbstract available
ALESSANDRINI J, Cox J, de Pokomandy A, Hart TA, et al Prevalence of Oral Human Papillomavirus Infection Among Urban Gay, Bisexual, and
Other Men Who Have Sex With Men in Canada, 2017-2019.
J Infect Dis. 2024 Jul 23:jiae345. doi: 10.1093. PubMedAbstract available
AUNG S, Novitsky V, Steingrimsson J, Gillani FS, et al Acquired Human Immunodeficiency Virus Type 1 Drug Resistance in Rhode Island,
USA, 2004-2021.
J Infect Dis. 2024 Jul 23:jiae344. doi: 10.1093. PubMedAbstract available
BLOOM N, Ramirez SI, Cohn H, Parikh UM, et al SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human
memory B cell epitope recognition suggesting antibody feedback.
J Infect Dis. 2024 Jul 22:jiae371. doi: 10.1093. PubMedAbstract available
AGRAWAL P, Giron LB, Singh S, Haw NJ, et al Pre-pandemic Metabolic Correlates of COVID-19 Severity and Long COVID Incidence
in People Living with HIV.
J Infect Dis. 2024 Jul 16:jiae362. doi: 10.1093. PubMedAbstract available
BLENKINSOP A, Pantazis N, Kostaki EG, Sofocleous L, et al Sources of Human Immunodeficiency Virus Infections Among Men Who Have Sex With
Men With a Migration Background: A Viral Phylogenetic Case Study in Amsterdam,
The Netherlands.
J Infect Dis. 2024 Jul 8:jiae267. doi: 10.1093. PubMedAbstract available
June 2024
REID TB, Godornes C, Campbell VL, Laing KJ, et al Treponema pallidum Periplasmic and Membrane Proteins Are Recognized by
Circulating and Skin CD4+ T Cells.
J Infect Dis. 2024 Jun 27:jiae245. doi: 10.1093. PubMedAbstract available
WANG F, Rademeyer K, Namuju OC, Abdusalaamu K, et al Post-mortem analysis of dolutegravir, tenofovir, lamivudine and efavirenz
penetration in multiple CNS compartments.
J Infect Dis. 2024 Jun 20:jiae325. doi: 10.1093. PubMedAbstract available
CHOW EPF, Stevens K, De Petra V, Chen MY, et al Prevalence of cefixime-resistant Neisseria gonorrhoeae in Melbourne, Australia,
2021-2022.
J Infect Dis. 2024 Jun 15:jiae313. doi: 10.1093. PubMedAbstract available
JACOBSON DL, Crider KS, DeMarrais P, Brummel S, et al Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood
Cell Folate Concentrations in Pregnant Women and Their Infants.
J Infect Dis. 2024 Jun 15:jiae308. doi: 10.1093. PubMedAbstract available
RUSHMORE J, Learner ER, Bernstein KT Expanding the Evidence Base for Improving Sexual Health Among Transgender
Communities: The Importance of Rigorous Epidemiologic Studies.
J Infect Dis. 2024;229:1603-1605. PubMed
AMSTUTZ A, Chammartin F, Audige A, Eichenberger AL, et al Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people
with compromised immune function (COVERALL-3).
J Infect Dis. 2024 Jun 7:jiae291. doi: 10.1093. PubMedAbstract available
May 2024
KANKAKA EN, Poon AFY, Quinn TC, Chang LW, et al Impact of variable sampling on estimates of HIV-1 reservoir formation dates.
J Infect Dis. 2024 May 31:jiae294. doi: 10.1093. PubMedAbstract available
DURSTENFELD MS, Wilson MP, Jankowski CM, Ditzenberger GL, et al Chronotropic Incompetence among People with HIV Improves with Exercise Training
in the Exercise for Healthy Aging Study.
J Infect Dis. 2024 May 28:jiae284. doi: 10.1093. PubMedAbstract available
SPRINGER YP, Tompkins ML, Newell K, Jones M, et al Characterizing the etiology of recurrent tuberculosis using whole genome
sequencing-Alaska, USA, 2008-2020.
J Infect Dis. 2024 May 24:jiae275. doi: 10.1093. PubMedAbstract available
ALLEN LI, Fraser H, Stone J, McAuley A, et al Testing and Treatment Interventions in Community Settings Key to Controlling a
Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in
Glasgow: A Modeling Study.
J Infect Dis. 2024 May 22:jiae206. doi: 10.1093. PubMedAbstract available
MCCLUSKEY SM, Muyindike WR, Nanfuka V, Omoding D, et al Population Effectiveness of Dolutegravir Implementation in Uganda - A Prospective
Observational Cohort Study (DISCO): 48-week Results.
J Infect Dis. 2024 May 16:jiae260. doi: 10.1093. PubMedAbstract available
SMITH CL, Didion E, Aung H, Tamilselvan B, et al Longitudinal analysis of nursing home residents' T cell responses after
SARS-CoV-2 mRNA vaccinations shows influence of biological sex and SARS-CoV-2
infection history.
J Infect Dis. 2024 May 14:jiae234. doi: 10.1093. PubMedAbstract available
MASIA M, Garcia JA, Garcia-Abellan J, Padilla S, et al Distinct gut microbiota signatures associated with progression of atherosclerosis
in people living with HIV.
J Infect Dis. 2024 May 14:jiae243. doi: 10.1093. PubMedAbstract available
MOTSOENENG BM, Dhar N, Nunes MC, Krammer F, et al Hemagglutinin stalk-specific Fc-mediated functions are associated with protection
against influenza-illness after seasonal influenza vaccination in pregnant women.
J Infect Dis. 2024 May 14:jiae241. doi: 10.1093. PubMedAbstract available
SERRANO-VILLAR S, Martinez E The Gut Microbiome: Another Piece in the Puzzle of HIV-Associated
Atherosclerosis.
J Infect Dis. 2024 May 14:jiae244. doi: 10.1093. PubMed
PATHELA P, Townsend MB, Kopping EJ, Tang J, et al Serological Evidence of Mpox Virus Infection During Peak Mpox Transmission in New
York City, July to August 2022.
J Infect Dis. 2024 May 13:jiae181. doi: 10.1093. PubMedAbstract available
NICHOLSON LK, Kofonow JM, Robertson CE, Wright T, et al Clinical and Microbial Determinants of Upper Respiratory Colonization with
Streptococcus pneumoniae and Native Microbiota in People with HIV-1 and Control
Adults.
J Infect Dis. 2024 May 8:jiae247. doi: 10.1093. PubMedAbstract available
SINGH OP, Chaubey R, Kushwaha AK, Fay MP, et al Visceral Leishmaniasis-Human Immunodeficiency Virus-Coinfected Patients Are
Highly Infectious to Sandflies in an Endemic Area in India.
J Infect Dis. 2024 May 7:jiae156. doi: 10.1093. PubMedAbstract available
WU L, Kinuthia J, Anderson PL, Baeten JM, et al Drug concentrations in hair and dried blood spots as PrEP adherence metrics
during pregnancy and postpartum.
J Infect Dis. 2024 May 3:jiae208. doi: 10.1093. PubMedAbstract available
BERKOWITZ SA The Benefits of Medically Tailored Meals for People Living with HIV.
J Infect Dis. 2024 May 2:jiae196. doi: 10.1093. PubMed
PALAR K, Sheira LA, Frongillo EA, O'Donnell AA, et al Food is Medicine for HIV: Improved health and hospitalizations in the Changing
Health through Food Support (CHEFS-HIV) pragmatic randomized trial.
J Infect Dis. 2024 May 2:jiae195. doi: 10.1093. PubMedAbstract available
April 2024
GILLIS N, Dickey BL, Colin-Leitzinger C, Tang YH, et al Clonal hematopoiesis in patients with HIV and cancer.
J Infect Dis. 2024 Apr 24:jiae212. doi: 10.1093. PubMedAbstract available
RIDDLER SA, Kelly CW, Hoesley CJ, Ho KS, et al A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir
Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention.
J Infect Dis. 2024 Apr 24:jiae211. doi: 10.1093. PubMedAbstract available
MORO RN, Mehaffy C, De P, Phillips E, et al Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing
Flu-like Reactions During Treatment of Latent Tuberculosis Infection.
J Infect Dis. 2024 Apr 19:jiae180. doi: 10.1093. PubMedAbstract available
NIKITIN D, Whittles LK, Imai-Eaton JW, White PJ, et al Cost-effectiveness of 4CMenB vaccination against gonorrhea: importance of dosing
schedule, vaccine sentiment, targeting strategy, and duration of protection.
J Infect Dis. 2024 Apr 17:jiae123. doi: 10.1093. PubMedAbstract available
MURENZI G, Kim HY, Mivumbi JP, Gasana J, et al Incidence, Clearance and Persistence of Penile High-Risk Human Papillomavirus
among Rwandan Men who have Sex with Men.
J Infect Dis. 2024 Apr 16:jiae190. doi: 10.1093. PubMedAbstract available
BEGRE L, Boyd A, Plissonnier ML, Testoni B, et al Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons
with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.
J Infect Dis. 2024 Apr 16:jiae189. doi: 10.1093. PubMedAbstract available
VAN TEIJLINGEN NH, van Smoorenburg MY, Sarrami-Forooshani R, Zijlstra-Willems EM, et al Prevotella timonensis bacteria associated with vaginal dysbiosis enhance HIV-1
susceptibility of vaginal CD4+ T cells.
J Infect Dis. 2024 Apr 4:jiae166. doi: 10.1093. PubMedAbstract available
BAR ZIV O, Cahn A, Jansen T, Istomin V, et al Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living with HIV-
Evaluation of Clinical and Microbiome Parameters.
J Infect Dis. 2024 Apr 1:jiae167. doi: 10.1093. PubMedAbstract available
BERENGUER J, Jarrin I, Bellon JM, Diez C, et al Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients with
HIV.
J Infect Dis. 2024 Apr 1:jiae168. doi: 10.1093. PubMedAbstract available
March 2024
XIU F, Flores Anato JL, Cox J, Grace D, et al Characteristics of the Sexual Networks of Men Who Have Sex With Men in Montreal,
Toronto, and Vancouver: Insights from Canada's 2022 Mpox Outbreak.
J Infect Dis. 2024;229. PubMedAbstract available
SNYDER RE, Saadeh K, Tang EC, Johnson KA, et al Sexual Exposures Associated With Mpox Infection: California, November 2022 to
June 2023.
J Infect Dis. 2024;229. PubMedAbstract available
OLSSON O, Sokilde R, Tesfaye F, Karlson S, et al Tuberculosis disease is associated with elevated plasma ribonuclease activity in
antiretroviral treatment-naive people with HIV.
J Infect Dis. 2024 Mar 25:jiae143. doi: 10.1093. PubMedAbstract available
ZEEB M, Frischknecht P, Huber M, Schenkel CD, et al Genetic diversity from proviral DNA as a proxy for time since HIV-1 infection.
J Infect Dis. 2024 Mar 20:jiae149. doi: 10.1093. PubMedAbstract available
GRUNER E, Grossegesse M, Stern D, Ober V, et al Mpox-specific immune responses elicited by vaccination or infection in people
living with HIV.
J Infect Dis. 2024 Mar 13:jiae138. doi: 10.1093. PubMedAbstract available
BURDORF R, Zhou S, Amon C, Long N, et al Impact Of Low-Frequency HIV-1 Drug Resistance Mutations On Antiretroviral Therapy
Outcomes.
J Infect Dis. 2024 Mar 11:jiae131. doi: 10.1093. PubMedAbstract available
COLON W, Oriol Mathieu V, Hural J, Hattingh L, et al HIV Diagnostics and Vaccines: It Takes Two to Tango.
J Infect Dis. 2024 Mar 7:jiae113. doi: 10.1093. PubMedAbstract available
WILCOX CS, Herbert C, Wang C, Ma Y, et al Signals From Inflamed Perivascular Adipose Tissue Contribute to Small Vessel
Dysfunction in Women Living With the Human Immunodeficiency Virus.
J Infect Dis. 2024 Mar 1:jiae094. doi: 10.1093. PubMedAbstract available
February 2024
XIAO G, Huang W, Zhong Y, Ou M, et al Uncovering the Bronchoalveolar Single-Cell Landscape of Patients With Pulmonary
Tuberculosis With Human Immunodeficiency Virus Type 1 Coinfection.
J Infect Dis. 2024 Feb 27:jiae042. doi: 10.1093. PubMedAbstract available
TU T, Ajoyan H, Nur Umami R, Veeraraghavan V, et al Inhibition of cellular factor TM6SF2 suppresses secretion pathways of Hepatitis
B, Hepatitis C and Hepatitis D viruses.
J Infect Dis. 2024 Feb 26:jiae098. doi: 10.1093. PubMedAbstract available
COLLAZOS J, Asensi V Non-invasive liver fibrosis markers in the evaluation of fibrosis regression
after direct-acting antiviral (DAA) therapy.
J Infect Dis. 2024 Feb 23:jiae095. doi: 10.1093. PubMed
RANDALL KL, Flesch IEA, Mei Y, Miosge LA, et al DOCK2-deficiency causes defects in anti-viral T cell responses and impaired
control of herpes simplex virus infection.
J Infect Dis. 2024 Feb 15:jiae077. doi: 10.1093. PubMedAbstract available